This is an extreme acceleration of what is happening in the US as well. Any time employment or compensation is based on research outcomes, it is by definition a monetary incentive to doctor your outcomes.
In China this was down to their ranking system and grant eligibility. In the US this usually happens inside companies (see literally the entire history of DuPont and the research they did, or all the research that is funded by Nestle or Petrochemical companies), or in order to secure or keep tenured positions, or retain grants.
Good research needs to be publicly-funded, and devoid (as much as possible , from a methodological standpoint) of desired outcomes.